Folium Europe, sells botanical Cannabidiol (CBD) and Tetrahydrocannabinol (THC) as Active Pharmaceutical Ingredients on a commercial scale.
Folium Europe is setting the highest standards to continue to bring you a premium product. See how we’ve grown to be Europe’s best established cannabinoid company.
Our complete line-up of hemp products are held to the highest industry standards to ensure the reliability of product performance and quality designed into our supply chain.
Folium Europe, sells botanical Cannabidiol (CBD) and Tetrahydrocannabinol (THC) as Active Pharmaceutical Ingredients on a commercial scale. The API’s are exclusively produced for us by EU-GMP/API license holder FeyeCon. Other botanical cannabinoid API’s are in the pipeline. Folium Europe works together with the client when it comes to the supply of a new API’s understanding volumes needs during the clinical development.
Folium Europe B.V.’s independent Novel Food dossier for botanical broad spectrum CBD, including all derived ingredients and white label finished products, is in de validation stage with UK Food Standards Agency (FSA). Awaiting approval to move forward to the authorization stage. This application is performed using our own resources, both financially as well as our extensive knowledge on regulation landscape and quality. In our opinion Europe will move to enforce the Novel Food legislation for CBD as has already been the case with the UK (FSA). In parallel, we are also preparing submission to the European Food Safety Authority (EFSA). In the business of cannabinoids quality will prevail.
